Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Thromboangiitis obliterans.

Literature DB >> 20421527

Thromboangiitis obliterans.

Gregory Piazza¹, Mark A Creager.

Abstract

Entities: Chemical Disease Gene Species

Mesh：

Year: 2010 PMID： 20421527 PMCID： PMC2880529 DOI： 10.1161/CIRCULATIONAHA.110.942383

Source DB: PubMed Journal: Circulation ISSN： 0009-7322 Impact factor: 29.690

× No keyword cloud information.

18 in total

Review 1. Thromboangiitis obliterans (Buerger's disease).

Authors: J W Olin
Journal: N Engl J Med Date: 2000-09-21 Impact factor: 91.245

2. Trial of iloprost versus aspirin treatment for critical limb ischaemia of thromboangiitis obliterans. The TAO Study.

Authors: J N Fiessinger; M Schäfer
Journal: Lancet Date: 1990-03-10 Impact factor: 79.321

3. Role of infrainguinal bypass in Buerger's disease: an eighteen-year experience.

Authors: T Sasajima; Y Kubo; M Inaba; K Goh; N Azuma
Journal: Eur J Vasc Endovasc Surg Date: 1997-02 Impact factor: 7.069

4. Antiphospholipid antibodies in thromboangiitis obliterans.

Authors: Lezek Maslowski; Robert McBane; Pawel Alexewicz; Waldemar E Wysokinski
Journal: Vasc Med Date: 2002 Impact factor: 3.239

5. Antiendothelial cell antibodies in thromboangiitis obliterans.

Authors: J Eichhorn; D Sima; C Lindschau; A Turowski; H Schmidt; W Schneider; H Haller; F C Luft
Journal: Am J Med Sci Date: 1998-01 Impact factor: 2.378

6. The altered hemorheologic parameters in thromboangiitis obliterans: a new insight.

Authors: A Kursat Bozkurt; Cengiz Koksal; Meltem Ercan
Journal: Clin Appl Thromb Hemost Date: 2004-01 Impact factor: 2.389

7. Intermittent compression pump for nonhealing wounds in patients with limb ischemia. The Mayo Clinic experience (1998-2000).

Authors: V M Montori; S J Kavros; E E Walsh; T W Rooke
Journal: Int Angiol Date: 2002-12 Impact factor: 2.789

8. Clinical and social consequences of Buerger disease.

Authors: Takashi Ohta; Hiroyuki Ishioashi; Minoru Hosaka; Ikuo Sugimoto
Journal: J Vasc Surg Date: 2004-01 Impact factor: 4.268

9. Cellular sensitivity to collagen in thromboangiitis obliterans.

Authors: R Adar; M Z Papa; Z Halpern; M Mozes; S Shoshan; B Sofer; H Zinger; M Dayan; E Mozes
Journal: N Engl J Med Date: 1983-05-12 Impact factor: 91.245

10. Long-term clinical outcome after intramuscular implantation of bone marrow mononuclear cells (Therapeutic Angiogenesis by Cell Transplantation [TACT] trial) in patients with chronic limb ischemia.

Authors: Satoaki Matoba; Tetsuya Tatsumi; Toyoaki Murohara; Tsutomu Imaizumi; Yousuke Katsuda; Masaaki Ito; Yoshihiko Saito; Shiro Uemura; Hiroshi Suzuki; Shinya Fukumoto; Yasutaka Yamamoto; Rie Onodera; Satoshi Teramukai; Masanori Fukushima; Hiroaki Matsubara
Journal: Am Heart J Date: 2008-09-19 Impact factor: 4.749

41 in total

Thromboangiitis obliterans.

Review 1. Thromboangiitis obliterans (Buerger's disease).

2. Trial of iloprost versus aspirin treatment for critical limb ischaemia of thromboangiitis obliterans. The TAO Study.

3. Role of infrainguinal bypass in Buerger's disease: an eighteen-year experience.

4. Antiphospholipid antibodies in thromboangiitis obliterans.

5. Antiendothelial cell antibodies in thromboangiitis obliterans.

6. The altered hemorheologic parameters in thromboangiitis obliterans: a new insight.

7. Intermittent compression pump for nonhealing wounds in patients with limb ischemia. The Mayo Clinic experience (1998-2000).

8. Clinical and social consequences of Buerger disease.

9. Cellular sensitivity to collagen in thromboangiitis obliterans.

10. Long-term clinical outcome after intramuscular implantation of bone marrow mononuclear cells (Therapeutic Angiogenesis by Cell Transplantation [TACT] trial) in patients with chronic limb ischemia.

Review 1. Thoracic sympathectomy: a review of current indications.

Review 2. Politics, culture, and the legitimacy of disease: the case of Buerger's disease.

3. Peripheral sympathetic block with therapeutic local anesthesia for the manage-ment of upper limb digital ischemia.

4. Nailfold capillaroscopy in Buerger's disease: A useful tool?

Review 5. Conditions presenting with symptoms of peripheral arterial disease.

6. The value of FDG-PET in the diagnosis of thromboangiitis obliterans--a case series.

7. The prolonged clotting time in two female patients with thromboangiitis obliterans.

Review 8. Nonatherosclerotic PAD: Approach to Exertional Pain in the Lower Extremities.

9. [Therapy of peripheral vessel stenosis and occlusion in patients with thromboangiitis obliterans].

10. Investigation of the Etiology of Anemia in Thromboangiitis Obliterans.